StockNow
Log in
U.S. Markets

McKesson (MCK) agrees to acquire pharma services group Precision Medicine Group from Blackstone (BX) for roughly USD 2.25bln

StockNow breaking-news AI analysis

McKesson agreed to acquire Precision Medicine Group for approximately USD 2.25 billion, integrating its clinical and biopharma commercialization capabilities into its Oncology & Multispecialty segment.

2 stocks
MCKMcKesson Corporation$884.80Current priceBXBlackstone Inc.$142.40Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
U.S. Economy

US ADP Employment Change Weekly 11.75K (Prev. 9.5K)

Commodities

Japanese Government is set to launch state support for construction of oil pipelines which bypass the Strait of Hormuz, Nikkei reports

Fed

Fed's Collins (2028 Voter) says inflation is still too high, and is concerned about price stability part of the Fed's mandate; labour market consistent with full employment, economy growing at a near-trend pace